Ekso Bionics Holdings Inc. announced it has appointed Ted Wang, PhD, to its board of directors.
“Ted’s strong track record of successful strategic, operational and financial management, combined with his deep knowledge of Ekso’s technology and end markets, make him extremely qualified to help guide our leadership team,” Thomas Looby, Ekso president and chief executive officer, said in a press release.
Wang is chief investment officer of Puissance Capital Management, a lead investor in Ekso’s recently completed rights offering, according to the release. Wang was a partner of Goldman, Sachs & Co. in New York prior to joining Puissance Capital Management. He spent 18 years at Goldman Sachs, during which time he held many leadership positions, according to the release.
“I am excited to join the Ekso Bionics board, and I look forward to helping the company realize the potential and promise of its innovative exoskeleton portfolio,” Wang said in the release. “Ekso has an extraordinary opportunity to expand its presence in key international markets, and I am committed to working with the Ekso management team to execute on that opportunity.”
Wang replaces Dan Boren, who joined the board of directors in April 2013 and resigned effective Sept. 19, 2017.